Amanye amagama: i-Octacosanol, i-1-Octacosanol, i-N-Octacosanol, i-Octacosyl Utshwala
I-Policosanol, isithasiselo sokudla, ingxube yezinyosi eziqhelelene ne-sugar cane yama-Cube. Iqukethe cishe i-octacosanol engama-60%.
I-policosanol ye-sugar ayitholakali kakhulu e-United States. Esikhundleni salokho, imikhiqizo ye-policosanol ethengiswa e-United States ngokuvamile ivela ku-bexis negciwane lengqolowa.
Ukusetshenziswa
Eminye imithi, i-policosanol ngokuvamile isetshenziselwa uketshezi oluphakeme .
Izinzuzo zezeMpilo
I-Policosanol isetshenziselwe ukwesekwa kokudla okunganciphisa i- cholesterol .
Nakuba ezinye izifundo zibonisa ukuthi i-policosanol ingasiza ekuvimbeleni ukwakheka kwe-cholesterol esibindi, iningi lezifundo eziphathelene ne-policosanol yokhukhamba yenziwe yiqembu elilodwa lokucwaninga eCuba elihilelekile kwi-patent policosanol.
Ucwaningo oluzimele olwanyatheliswa kuyi- Journal of the American Medical Association ngo-2006 aluzange luzuze noma iyiphi inzuzo ye-policosanol, ngisho nasezingeni eliphezulu, emazingeni e-cholesterol. Lokhu kutholakala kukungabaza ngokuthembeka kocwaningo lwaseCuban nge-policosanol.
Umthamo ovamile we-policosanol osetshenziselwa ukuhlola ube ngu-5 kuya ku-10 mg kabili nsuku zonke. Izifundo ngokuvamile zithola ukuthi kungathatha izinyanga ezimbili ukuqaphela izinzuzo.
Amapulangwe
Nakuba ukuthembeka kwezifundo zaseCuban kuye kwabuzwa, imiphumela emibi ye-policosanol ebikelelwe kulesi silingo sekuye kwaba mnandi futhi yesikhashana.
Bafaka ukuhlushwa, ukushisa isikhumba, ikhanda lokushona , ukulala nokushona.
I-Policosanol ingakhuphula umphumela wemithi ephazamisa ukugaya igazi noma izidakamizwa eziphikisana ne-plateletlet, njenge-aspirin, i-warfarin (i-Coumadin), i-heparin, i-clopidogrel (i-Plavix), i-ticlopidine (i-Ticlid), noma i-pentoxifylline (i-Trental), noma i-supplement njengegalikhi , i-ginkgo, noma i-vitamin e-dose ephakeme.
I-Policosanol ingathuthukisa imiphumela nemiphumela emibi ye-levodopa, imithi esetshenziselwa isifo sikaParkinson.
Izindleko azange zihlolwe ukuphepha futhi ngenxa yokuthi izithako zokudla ngokuvamile azihambisani nomthetho, okuqukethwe kwemikhiqizo ethile kungase kuhluke kulokho okushiwo kwilebula lomkhiqizo. Futhi khumbula ukuthi ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imithi asungulwe ..
Ukusebenzisa i-Policosanol yezeMpilo
Ngenxa yokungabi nobufakazi obusekelayo, kusheshe ukuba batusa i-policosanol yokwelashwa kwe-cholesterol ephakeme. Uma ucabangela ukuyisebenzisa, khuluma nomhlinzeki wakho oyinhloko wokunakekelwa kuqala. Ukwelapha isimo futhi ukugwema noma ukubambezela ukunakekelwa okujwayelekile kungaba nemiphumela emibi.
> Imithombo:
> Arruzazabala ML, Molina V, Mas R, Fernandez L, Carbajal D, Valdes S, Castano G. Antiplatelet Imiphumela yePollicosanol (20 no 40 Mg / Usuku) kumaVolontiya aMpilo kanye neziguli zeDyslipidaemic. I-Pharmacology and Experimental Pharmacology & Physiology. (2002) 29 (10): 891-7.
> Berthold HK, Unverdorben S, Degenhardt R et al. Umphumela wePolicosanol kumazinga e-Lipid Phakathi kweziguli ezine-Hypercholesterolemia noma Hyperlipidemia ehlanganisiwe: Isivivinyo Esilawulwe Ngokungahleliwe. I-JAMA. (2006) 295: 2262-9.
> Castano G, Mas R, Fernandez L, Illnait J, Mendoza S, Gamez R, Fernandez J, Mesa M. Ukuqhathaniswa nemiphumela ye-D-003 kanye nePolicosanol (5 no-10 Mg / Usuku) ezigulini ezine-Type II Hypercholesterolemia : Isifundo Esingahleliwe, Esibanjwe Ngesibili. Izidakamizwa Ngaphansi Ucwaningo Lokuhlola Nezokwelapha. (2005) 31 Ukusekela: 31-44.
> Castano G, Mas R, Fernandez L, Illnait J, Gamez R, Alvarez E. Imiphumela yePolicosanol 20 Versus 40 Mg / Usuku ekwelapheni kweziguli ezine-Type II Hypercholesterolemia: Isifundo se-Double-Blind Study se-6-Month. I-International Journal of Clinical Pharmacology Research. (2001) 21 (1): 43-57.
> Castano G, Mas R, Gamez R, Fernandez J, Illnait J, Fernandez L, Mendoza S, Mesa M, Gutierrez JA, Lopez E. Ukusebenzisana Okuhambisana NePolicosanol kanye neBeta-Blockers kwabakhulile asebekhulile. I-International Journal of Clinical Pharmacology Research. (2004) 24 (2-3): 65-77.
> Castano G, Mas R, Gamez R, Fernandez L, Illnait J. Imiphumela yePolicosanol kanye neTiclopidine ezigulini ezinezikhalazo ezingekho emthethweni: Isifundo sokuqhathaniswa nokuPhepha okuPhezulu okuPhezulu. I-Angiology. (2004) 55 (4): 361-71.
> Lin Y, Rudrum M, van der Wielen RP, Trautwein EA, McNeill G, Sierksma A, Meijer GW. I-Wheat Germ Policosanol Yehlulekile Ukunciphisa I-Cholesterol Yama-Plasma Ezifundweni Ezinemiqondo Ejwayelekile Yokwakhiwa Kwe-Cholesterol Elingavamile. I-Metabolism. (2004) 53 (10): 1309-14.
Ukwaziswa okuqukethwe kule sayithi kuhloswe ngezinhloso zemfundo kuphela futhi akusilo esikhundleni seseluleko, ukuxilongwa noma ukwelashwa udokotela olayisensi. Akuhloswe ukumboza zonke izinyathelo zokuphepha, ukusebenzisana kwezidakamizwa, isimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.